Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Public Citizen continues to press Meridia withdrawal

Executive Summary

Public Citizen submits second petition calling for FDA to ban Abbott's diet drug Meridia (sibutramine). The first petition, submitted March 19, 2002, cited 19 deaths from cardiovascular disease from February 1998 to September 2001. The 1second petition, submitted Sept. 3, includes 30 additional reports of cardiovascular deaths in Meridia patients. Abbott met with FDA Chief Counsel Dan Troy June 11 to discuss Meridia labeling (2"The Pink Sheet" July 21, 2003, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel